Sign up for the QMED & MD+DI Daily newsletter.
CMS: PainShield Not Covered by Medicare, Medicaid
NanoVibronix plans to address CMS concerns and resubmit an application for additional review.
August 30, 2023
1 Min Read
GOCMEN / iStock via Getty Images
The same week NanoVibronix announced it had extended its distribution agreement with Ultra Pain products, the company also received the disappointing news that the Centers for Medicare and Medicaid Services (CMS) decided its PainShield Surface Acoustic Wave (SAW) portable ultrasonic therapeutic device did not fall within the Durable Medical Equipment, Prosthetics, Orthotics, and Supplies benefit category.
The decision was part of the publication of CMS’s Aug. 21 Healthcare Common Procedure Coding System (HCPCS) Application Summaries, Coding Decisions, and Benefit Category & Payment Determinations for the first bi-annual 2023 Non-Drug and Non-Biological Items and Services.
CMS’ decision means that the PainShield device is not currently reimbursable under Medicare and Medicaid. The company said they plan to address CMS concerns and resubmit an application for additional review.
In a statement addressing CMS’s decision, Brain Murphy, CEO of NanoVibronix, said, “We are working to fully understand the implications of CMS’ HCPCS summaries and payment determinations as it relates to PainShield. Over the coming weeks, we will be developing an action plan to address CMS’ concerns and, at the very least, resubmit an application for additional review. We are exploring several options with our legal and technical teams.”
“We continue to believe that PainShield provides an effective therapy for pain management and could greatly benefit many of the more than 150 million patients covered by Medicare and Medicaid insurance,” he continued. “Despite our disappointment with the recent decision from CMS, we continue to grow the distribution of PainShield in the workers’ compensation, personal injury and Veterans’ Administration spaces.”
About the Author(s)
Managing Editor, MD+DI
Katie Hobbins is managing editor for MD+DI and joined the team in July 2022. She boasts multiple previous editorial roles in print and multimedia medical journalism, including dermatology, medical aesthetics, and pediatric medicine. She graduated from Cleveland State University in 2018 with a bachelor's degree in journalism and promotional communications. She enjoys yoga, hand embroidery, and anything DIY. You can reach her at [email protected].
You May Also Like
Sustainable Manufacturing Expo Hits North AmericaFeb 22, 2024|4 Min Read
Medtronic Doubles Down on Sustainability EffortsFeb 22, 2024|1 Min Read
Top Medical Device M&AFeb 21, 2024|1 Min Read
FDA Urges Independent Verification of Third-Party Testing DataFeb 21, 2024|2 Min Read